Cargando…
Persistent Psychosis after Abuse of High Dose of Zolpidem
BACKGROUND: Zolpidem is a non-benzodiazepine medication which selectively affects GABA A receptors and treats insomnia. There are numerous reports of psychosis following the consumption of zolpidem all of which recovered after stopping the medication. CASE REPORT: A 27 year old male law student, who...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354222/ https://www.ncbi.nlm.nih.gov/pubmed/25984284 |
_version_ | 1782360723253362688 |
---|---|
author | Eslami-Shahrbabaki, Mahin Barfeh, Babak Nasirian, Mansoureh |
author_facet | Eslami-Shahrbabaki, Mahin Barfeh, Babak Nasirian, Mansoureh |
author_sort | Eslami-Shahrbabaki, Mahin |
collection | PubMed |
description | BACKGROUND: Zolpidem is a non-benzodiazepine medication which selectively affects GABA A receptors and treats insomnia. There are numerous reports of psychosis following the consumption of zolpidem all of which recovered after stopping the medication. CASE REPORT: A 27 year old male law student, who was treated with 10 mg zolpidem due to insomnia, increased the dosage to 500 mg during 3 months. Not only was his insomnia remained untreated, but also he gradually became isolated, suspicious, and aggressive, and dropped out of university. He was then hospitalized in a psychiatric ward for 2 months, and was treated with antipsychotics and gradual discontinuation of zolpidem. With no improvement in psychosis and sleep improvement he was discharged. After two weeks he was hospitalized again and went under electroconvulsive therapy (ECT) and antipsychotic therapy, and was discharged with relative improvement. Now, after three years, he is diagnosed with schizophrenia and with modest improvements he is under care and treatment. CONCLUSION: Zolpidem is a fairly useful medication for treating sleep problems, especially improving beginning of sleep. However, physicians ýand clinicians should consider the conditions, predispositions, and personal and family history of types of psychosis, alcohol and drug abuse in the comprehensive assessment and treatment plan for patients with insomnia. |
format | Online Article Text |
id | pubmed-4354222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-43542222015-05-15 Persistent Psychosis after Abuse of High Dose of Zolpidem Eslami-Shahrbabaki, Mahin Barfeh, Babak Nasirian, Mansoureh Addict Health Case Report BACKGROUND: Zolpidem is a non-benzodiazepine medication which selectively affects GABA A receptors and treats insomnia. There are numerous reports of psychosis following the consumption of zolpidem all of which recovered after stopping the medication. CASE REPORT: A 27 year old male law student, who was treated with 10 mg zolpidem due to insomnia, increased the dosage to 500 mg during 3 months. Not only was his insomnia remained untreated, but also he gradually became isolated, suspicious, and aggressive, and dropped out of university. He was then hospitalized in a psychiatric ward for 2 months, and was treated with antipsychotics and gradual discontinuation of zolpidem. With no improvement in psychosis and sleep improvement he was discharged. After two weeks he was hospitalized again and went under electroconvulsive therapy (ECT) and antipsychotic therapy, and was discharged with relative improvement. Now, after three years, he is diagnosed with schizophrenia and with modest improvements he is under care and treatment. CONCLUSION: Zolpidem is a fairly useful medication for treating sleep problems, especially improving beginning of sleep. However, physicians ýand clinicians should consider the conditions, predispositions, and personal and family history of types of psychosis, alcohol and drug abuse in the comprehensive assessment and treatment plan for patients with insomnia. Kerman University of Medical Sciences 2014 /pmc/articles/PMC4354222/ /pubmed/25984284 Text en © 2014 Kerman University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Case Report Eslami-Shahrbabaki, Mahin Barfeh, Babak Nasirian, Mansoureh Persistent Psychosis after Abuse of High Dose of Zolpidem |
title | Persistent Psychosis after Abuse of High Dose of Zolpidem |
title_full | Persistent Psychosis after Abuse of High Dose of Zolpidem |
title_fullStr | Persistent Psychosis after Abuse of High Dose of Zolpidem |
title_full_unstemmed | Persistent Psychosis after Abuse of High Dose of Zolpidem |
title_short | Persistent Psychosis after Abuse of High Dose of Zolpidem |
title_sort | persistent psychosis after abuse of high dose of zolpidem |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354222/ https://www.ncbi.nlm.nih.gov/pubmed/25984284 |
work_keys_str_mv | AT eslamishahrbabakimahin persistentpsychosisafterabuseofhighdoseofzolpidem AT barfehbabak persistentpsychosisafterabuseofhighdoseofzolpidem AT nasirianmansoureh persistentpsychosisafterabuseofhighdoseofzolpidem |